Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Endocannabinoid-mediated retrograde modulation of synaptic transmission.

Ohno-Shosaku T, Kano M.

Curr Opin Neurobiol. 2014 Dec;29:1-8. doi: 10.1016/j.conb.2014.03.017. Epub 2014 Apr 18. Review.

PMID:
24747340
2.

Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.

Lee SH, Ledri M, Tóth B, Marchionni I, Henstridge CM, Dudok B, Kenesei K, Barna L, Szabó SI, Renkecz T, Oberoi M, Watanabe M, Limoli CL, Horvai G, Soltesz I, Katona I.

J Neurosci. 2015 Jul 8;35(27):10039-57. doi: 10.1523/JNEUROSCI.4112-14.2015.

3.

Why do cannabinoid receptors have more than one endogenous ligand?

Di Marzo V, De Petrocellis L.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3216-28. doi: 10.1098/rstb.2011.0382. Review.

4.

Cerebellar endocannabinoids: retrograde signaling from purkinje cells.

Marcaggi P.

Cerebellum. 2015 Jun;14(3):341-53. doi: 10.1007/s12311-014-0629-5. Review.

PMID:
25520276
5.

Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.

Mátyás F, Urbán GM, Watanabe M, Mackie K, Zimmer A, Freund TF, Katona I.

Neuropharmacology. 2008 Jan;54(1):95-107. Epub 2007 Jun 22.

6.

2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.

Llorente-Berzal A, Terzian AL, di Marzo V, Micale V, Viveros MP, Wotjak CT.

Psychopharmacology (Berl). 2015 Aug;232(15):2811-25. doi: 10.1007/s00213-015-3917-y. Epub 2015 Mar 28.

PMID:
25814137
7.

Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.

Di S, Itoga CA, Fisher MO, Solomonow J, Roltsch EA, Gilpin NW, Tasker JG.

J Neurosci. 2016 Aug 10;36(32):8461-70. doi: 10.1523/JNEUROSCI.2279-15.2016.

8.

Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.

Nyilas R, Gregg LC, Mackie K, Watanabe M, Zimmer A, Hohmann AG, Katona I.

Eur J Neurosci. 2009 May;29(10):1964-78. doi: 10.1111/j.1460-9568.2009.06751.x. Epub 2009 May 9.

9.

A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons.

Edwards JG, Gibson HE, Jensen T, Nugent F, Walther C, Blickenstaff J, Kauer JA.

Hippocampus. 2012 Feb;22(2):209-21. doi: 10.1002/hipo.20884. Epub 2010 Nov 10.

10.

Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol.

Hashimotodani Y, Ohno-Shosaku T, Yamazaki M, Sakimura K, Kano M.

J Neurosci. 2011 Feb 23;31(8):3104-9. doi: 10.1523/JNEUROSCI.6000-10.2011.

11.

Control of synaptic function by endocannabinoid-mediated retrograde signaling.

Kano M.

Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(7):235-50. Review.

12.

Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.

Aaltonen N, Riera Ribas C, Lehtonen M, Savinainen JR, Laitinen JT.

Eur J Pharm Sci. 2014 Jan 23;51:87-95. doi: 10.1016/j.ejps.2013.08.035. Epub 2013 Sep 3.

PMID:
24012970
13.

Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses.

Haj-Dahmane S, Shen RY, Elmes MW, Studholme K, Kanjiya MP, Bogdan D, Thanos PK, Miyauchi JT, Tsirka SE, Deutsch DG, Kaczocha M.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3482-3487. doi: 10.1073/pnas.1721339115. Epub 2018 Mar 12.

14.

Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.

Adermark L, Lovinger DM.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20564-9. Epub 2007 Dec 11.

15.

Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.

Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Baer WU, Freiman I.

J Physiol. 2006 Nov 15;577(Pt 1):263-80. Epub 2006 Sep 14.

16.

Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus.

Yang K, Lei G, Xie YF, MacDonald JF, Jackson MF.

Hippocampus. 2014 Dec;24(12):1601-14. doi: 10.1002/hipo.22339. Epub 2014 Aug 20.

PMID:
25087967
18.

Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.

Shimizu T, Tanaka K, Shimizu S, Higashi Y, Yawata T, Nakamura K, Taniuchi K, Ueba T, Yuri K, Saito M.

Neuropharmacology. 2015 Aug;95:278-89. doi: 10.1016/j.neuropharm.2015.03.034. Epub 2015 Apr 14.

PMID:
25882827
19.
20.

Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus.

Yoshida T, Uchigashima M, Yamasaki M, Katona I, Yamazaki M, Sakimura K, Kano M, Yoshioka M, Watanabe M.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3059-64. doi: 10.1073/pnas.1012875108. Epub 2011 Jan 31.

Supplemental Content

Support Center